Literature DB >> 9124848

Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates.

M A Ramsey1, S F Bradley, C A Kauffman, T M Morton.   

Abstract

Low- and high-level mupirocin resistance have been reported in Staphylococcus aureus. The expression of plasmid-encoded mupA is responsible for high-level mupirocin resistance. Low-level mupirocin-resistant strains do not contain plasmid-encoded mupA, and a chromosomal location for this gene has not previously been reported. We examined high- and low-level mupirocin-resistant S. aureus strains to determine if mupA was present on the chromosome of low-level-resistant isolates. Southern blot analysis of DNA from four mupirocin-resistant strains identified mupA in both high- and low-level mupirocin-resistant strains. Low-level mupirocin-resistant strains contained a copy of mupA on the chromosome, while the high-level mupirocin-resistant isolate contained a copy of the gene on the plasmid. PCR amplification of genomic DNA from each mupirocin-resistant strain resulted in a 1.65-kb fragment, the predicted product from the intragenic mupA primers. This is the first report of a chromosomal location for the mupA gene conferring low-level mupirocin resistance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9124848      PMCID: PMC163629     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Mupirocin-resistant Staphylococcus aureus.

Authors:  B D Cookson; R W Lacey; W C Noble; D S Reeves; R Wise; R J Redhead
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 2.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

3.  Nasal carriage of gentamicin and methicillin resistant Staphylococcus aureus treated with topical pseudomonic acid.

Authors:  J E Dacre; A M Emmerson; E A Jenner
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

4.  Staphylococcus aureus resistant to mupirocin.

Authors:  G E Smith; C T Kennedy
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

5.  Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase.

Authors:  J Hughes; G Mellows
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

6.  Characterization of a conjugative staphylococcal mupirocin resistance plasmid.

Authors:  T M Morton; J L Johnston; J Patterson; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Methicillin-resistant staphylococcal colonization and infection in a long-term care facility.

Authors:  R R Muder; C Brennen; M M Wagener; R M Vickers; J D Rihs; G A Hancock; Y C Yee; J M Miller; V L Yu
Journal:  Ann Intern Med       Date:  1991-01-15       Impact factor: 25.391

8.  Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment.

Authors:  D R Reagan; B N Doebbeling; M A Pfaller; C T Sheetz; A K Houston; R J Hollis; R P Wenzel
Journal:  Ann Intern Med       Date:  1991-01-15       Impact factor: 25.391

9.  In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus.

Authors:  M W Casewell; R L Hill
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

10.  Cloning of the gene conferring resistance to mupirocin in Staphylococcus aureus.

Authors:  K G Dyke; S P Curnock; M Golding; W C Noble
Journal:  FEMS Microbiol Lett       Date:  1991-01-15       Impact factor: 2.742

View more
  23 in total

1.  Characterization of the mupA gene in strains of methicillin-resistant Staphylococcus aureus with a low level of resistance to mupirocin.

Authors:  S Fujimura; A Watanabe; D Beighton
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions.

Authors:  Elaine S Walker; Foster Levy; Mahmoud Shorman; Gerard David; Jehad Abdalla; Felix A Sarubbi
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism.

Authors:  Daniel G Driscoll; Casey L Young; Urs A Ochsner
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

4.  Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

5.  Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea.

Authors:  Jae Il Yoo; Eun Shim Shin; Jeong Ok Cha; Jeom Kyu Lee; Young Hee Jung; Kyeong Min Lee; Bong Su Kim; Yeong Seon Lee
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

6.  High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center.

Authors:  Linda L Han; Linda K McDougal; Rachel J Gorwitz; Kenneth H Mayer; Jean B Patel; Janet M Sennott; John L Fontana
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

7.  Characterization of mupirocin-resistant Staphylococcus aureus from different geographic areas.

Authors:  M A Ramsey; S F Bradley; C A Kauffman; T M Morton; J E Patterson; D R Reagan
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

8.  Phenotypic and genotypic mupirocin resistance among Staphylococci causing prosthetic joint infection.

Authors:  Margalida Rotger; Andrej Trampuz; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

9.  Antibacterial activity of REP8839, a new antibiotic for topical use.

Authors:  Ian A Critchley; Casey L Young; Kimberley C Stone; Urs A Ochsner; Joseph Guiles; Ted Tarasow; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

10.  Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance.

Authors:  Jin Ah Yang; Dae Won Park; Jang Wook Sohn; In Seok Yang; Kyung Hyun Kim; Min Ja Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.